Mechanism of action and clinical use of Ca++-antagonists.
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D004110:Diltiazem / Q000494:pharmacology; D004594:Electrophysiology; D006331:Heart Diseases / Q000188:drug therapy*; D006801:Humans; D009132:Muscles / Q000502:physiology; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem; D002118:Calcium